A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.

by Kate Yandell

A study sheds light on predicting immunotherapy response, and a company starts testing a digital chemotherapy pill.

by Kate Yandell

Government guidance asks hospitals to post prices online, and a study shows that cancer patients are less likely to enroll in clinical trials if they have coexisting health conditions.

by Kate Yandell

A financial transparency law goes into effect, researchers investigate a link between hot flashes and breast cancer, and the hunt for a better synthetic cell culture medium.

by Brad Jones

Judicial threats to the Affordable Care Act continue, and a study investigates the long-term risks of chemotherapy.

by Kate Yandell and Marci A. Landsmann

A long-term trial presents new evidence on who should have surgery for localized prostate cancer, and a review finds that women are temporarily at increased risk of breast cancer after giving birth.

by Kate Yandell

A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.

by Kate Yandell

A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.

by Kate Yandell

A study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.

by Bradley Jones

A study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.

by Kate Yandell